Target Name: NKD1
NCBI ID: G85407
Review Report on NKD1 Target / Biomarker Content of Review Report on NKD1 Target / Biomarker
NKD1
Other Name(s): naked-1 | hNkd | Naked-1 | Protein naked cuticle homolog 1 | Naked cuticle-1 | NKD1, WNT signaling pathway inhibitor | naked cuticle-1 | hNkd1 | Dvl-binding protein | naked cuticle homolog 1 | NKD inhibitor of WNT signaling pathway 1 | NKD1_HUMAN | Naked1

Understanding The Role of NKD1 in Human Diseases

NKD1, or naked-1, is a protein that is expressed in most tissues of the body. It is a member of the nucleotide-binding oligomerization domain family (NOD) and is involved in various cellular processes such as DNA replication, transcription, and repair. Despite its importance, NKD1 is not well understood, and there are limited research studies on its role in human diseases.

One of the reasons for the lack of research is that NKD1 is a hard-to-modify protein, which makes it difficult to study. NKD1 has a large and complex structure, and it is surrounded by various domains that make it difficult to introduce changes to the protein. Additionally, NKD1 is a nuclear protein, which means that it is mostly localized in the nucleus of the cell. This makes it difficult to study the protein in live cells, as the nucleus is not easily accessible.

Despite these challenges, researchers have made some progress in understanding the biology of NKD1. One of the key findings is that NKD1 is involved in various cellular processes that are important for human health. For example, NKD1 is involved in the regulation of DNA replication, which is critical for cell growth and division. Additionally, NKD1 is involved in the regulation of gene expression, which is important for the development and progression of many diseases.

Another finding is that NKD1 is involved in the regulation of cellular signaling pathways. For example, NKD1 is involved in the regulation of the DNA damage response, which is important for the regulation of cell cycle progression and the maintenance of cellular stability. Additionally, NKD1 is involved in the regulation of the cell signaling pathway known as the T-cell receptor signaling pathway, which is important for the development and function of T-cells.

In addition to its role in cellular signaling pathways, NKD1 is also involved in the regulation of cellular processes that are important for human health. For example, NKD1 is involved in the regulation of the production of antibodies, which are important for the immune system. Additionally, NKD1 is involved in the regulation of the production of cell surface molecules, such as adhesion molecules and integrins, which are important for cell-cell and cell-tissue interactions.

Despite these findings, the role of NKD1 in human diseases is not well understood. There are no known diseases that are specifically caused by the absence of NKD1. Additionally, the lack of research on NKD1 makes it difficult to study its potential as a drug target or biomarker.

In conclusion, NKD1 is a protein that is expressed in most tissues of the body. While its role in cellular processes is well understood, the lack of research into its potential as a drug target or biomarker makes it difficult to study its importance in human diseases . Further research is needed to fully understand the role of NKD1 in human health and to explore its potential as a drug target or biomarker.

Protein Name: NKD Inhibitor Of WNT Signaling Pathway 1

Functions: Cell autonomous antagonist of the canonical Wnt signaling pathway. May activate a second Wnt signaling pathway that controls planar cell polarity

The "NKD1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about NKD1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

NKD2 | NKG7 | NKILA | NKIRAS1 | NKIRAS2 | NKPD1 | NKRF | NKTR | NKX1-1 | NKX1-2 | NKX2-1 | NKX2-1-AS1 | NKX2-2 | NKX2-3 | NKX2-4 | NKX2-5 | NKX2-6 | NKX2-8 | NKX3-1 | NKX3-2 | NKX6-1 | NKX6-2 | NKX6-3 | NLE1 | NLGN1 | NLGN1-AS1 | NLGN2 | NLGN3 | NLGN4X | NLGN4Y | NLK | NLN | NLRC3 | NLRC4 | NLRC4 Inflammasome | NLRC5 | NLRP1 | NLRP1 Inflammasome | NLRP10 | NLRP11 | NLRP12 | NLRP13 | NLRP14 | NLRP2 | NLRP2B | NLRP3 | NLRP3 Inflammasome | NLRP3P1 | NLRP4 | NLRP5 | NLRP6 | NLRP7 | NLRP8 | NLRP9 | NLRP9P1 | NLRX1 | NMB | NMBR | NMD3 | NMDA receptor | NME1 | NME1-NME2 | NME2 | NME2P1 | NME3 | NME4 | NME5 | NME6 | NME7 | NME8 | NME9 | NMI | NMNAT1 | NMNAT2 | NMNAT3 | NMRAL1 | NMRAL2P | NMRK1 | NMRK2 | NMS | NMT1 | NMT2 | NMTRQ-TTG10-1 | NMTRQ-TTG12-1 | NMTRV-TAC1-1 | NMU | NMUR1 | NMUR2 | NNAT | NNMT | NNT | NNT-AS1 | NOA1 | NOB1 | NOBOX | NOC2L | NOC2LP2 | NOC3L | NOC4L | NOCT